/R E P E A T -- Notice to the media - COVID-19 Update (June 29, 2020) - Government of Canada officials to provide a media technical briefing on coronavirus disease/
OTTAWA, ON, June 29, 2020 /CNW/ - Government of Canada officials will hold a media technical briefing on data and modelling informing public health action on coronavirus disease (COVID-19).
Date June 29, 2020
Time 12:00 PM (EDT)
Location West Block, Room 225 Parliament Hill Wellington Street, Ottawa, Ontario
The Media Technical Briefing will also be held by teleconference.
Toll-free (Canada/US) dial-in number: 1-866-206-0153 Local dial-in number: 613-954-9003
Passcode: 1622050#
NOTE: To obtain a copy of the briefing package, please RSVP by email at [email protected]
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...
